Amgen B.V.
Corporate group: Amgen Group · HQ: United States
Total cases
1
Claimant-side
0
Respondent-side
1
Amgen B.V. has been party to one Unified Patent Court case, as respondent. The case on record is UPC CFI 505/2023 at the Dusseldorf Local Division, brought by Sanofi Biotechnology SAS. Its most recent decision on the merits was in UPC CFI 505/2023 at the Dusseldorf Local Division on 13 May 2025: no infringement found.